KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Staphylococci (Quinupristin/Dalfopristin-resistant)

• Staphylococci
• Staphylococci (CN11 + coagulase-negative + methicillin-resistant)
• Staphylococci (CN18 + coagulase-negative + methicillin-resistant)
• Staphylococci (CN19 + coagulase-negative + methicillin-resistant)
• Staphylococci (CN20 + coagulase-negative + methicillin-susceptible)
• Staphylococci (CN3 + coagulase-negative + methicillin-susceptible)
• Staphylococci (CN5 + coagulase-negative + methicillin-resistant)
• Staphylococci (CN6 + coagulase-negative + methicillin-susceptible)
• Staphylococci (coagulase negative + methicillin-resistant)
• Staphylococci (coagulase negative + methicillin-susceptible)
• Staphylococci (coagulase-negativ)
• Staphylococci (coagulase-negative + 1990-1994)
• Staphylococci (coagulase-negative + 1990-2004)
• Staphylococci (coagulase-negative + 1995-1999)
• Staphylococci (coagulase-negative + 2000-2004)
• Staphylococci (coagulase-negative + 284)
• Staphylococci (coagulase-negative + beef isolate + Korea)
• Staphylococci (coagulase-negative + erythromycin-resistant)
• Staphylococci (coagulase-negative + erythromycin-susceptible)
• Staphylococci (coagulase-negative + ESBL)
• Staphylococci (coagulase-negative + methicillin-resistant)
• Staphylococci (coagulase-negative + methicillin-susceptible)
• Staphylococci (coagulase-negative + non-ESBL)
• Staphylococci (coagulase-negative + oxacillin-resistant)
• Staphylococci (coagulase-negative + oxacillin-susceptible)
• Staphylococci (coagulase-negative + pork isolate + Korea)
• Staphylococci (coagulase-negative + quinolone-resistant)
• Staphylococci (coagulase-negative + quinolone-susceptible)
• Staphylococci (coagulase-negative)
• Staphylococci (constitutively erm(C))
• Staphylococci (erm(C)-inducible)
• Staphylococci (erythromycin-susceptible)
• Staphylococci (GC 4547 + coagulase-negative + methicillin-resistant)
• Staphylococci (GC 4549 + coagulase-negative)
• Staphylococci (group A)
• Staphylococci (group B)
• Staphylococci (group C)
• Staphylococci (group G)
• Staphylococci (I-10925 + coagulase-negative)
• Staphylococci (Lancefield group A)
• Staphylococci (methicillin-resistant)
• Staphylococci (methicillin-susceptible)
• Staphylococci (msr)
• Staphylococci (Quinupristin/Dalfopristin-resistant)
• Staphylococci (teicoplanin-resistant + coagulase-negative)
• Staphylococci (vancomycin-intermediate)
• Staphylococci (vcoagulase-negative + methicillin-susceptible)

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8